![Rémi Droller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rémi Droller
Presidente en
Dyncaure SAS
.
Perfil
Rémi Droller is currently the Chairman at Dyncaure SAS, Director at Sterispine, Director at Imcheck Therapeutics SAS, Director at Vico Therapeutics BV, Director at Flamingo Therapeutics BV, Director at Pharvaris GmbH, Member-Supervisory Board at AM-Pharma Holding BV, Member-Supervisory Board at AM-Pharma BV, Managing Partner at Kurma Partners SA, and Member-Supervisory Board at Dynacure SA. He previously held positions as Chairman at Step Pharma SAS, Director at IntegraGen SA, Director at Valerio Therapeutics SA, Director at Zealand Pharma A, Director at Domain Therapeutics SA, Director at Novagali Pharma SA, Director at Theradiag SA, Director at OxThera AB, Director at Adocia SA, Independent Director at Orphazyme A, Director at STAT-Dx Life SL, Director at Key Neurosciences SAS, Non-Executive Director at Pharvaris NV, Partner at Eurazeo Investment Manager - EIM SA, Member-Supervisory Board at Prosensa Holding NV, and Head-Analysis at CDC Entreprises Innovation.
Dr. Droller graduated from Université Pierre et Marie Curie, AgroParisTech, and Nova School of Business & Economics.
Cargos activos de Rémi Droller
| Empresas | Cargo | Inicio |
|---|---|---|
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Inversor de Capital Privado | 01/09/2010 |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Director/Miembro de la Junta | - |
Sterispine | Director/Miembro de la Junta | - |
Dyncaure SAS
 Dyncaure SAS Pharmaceuticals: MajorHealth Technology Manufactures non-therapeutic products | Presidente | - |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Director/Miembro de la Junta | - |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Director/Miembro de la Junta | - |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Director/Miembro de la Junta | - |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Miembro de la Junta | 01/04/2016 |
Antiguos cargos conocidos de Rémi Droller.
| Empresas | Cargo | Fin |
|---|---|---|
| PHARVARIS N.V. | Director/Miembro de la Junta | 22/12/2021 |
| ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░ ░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Rémi Droller.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
68
Relaciones de 1er grado
29
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 29 |
|---|---|
IntegraGen SA
 IntegraGen SA Medical/Nursing ServicesHealth Services Develops cutting edge genome analysis products | Health Services |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Eurazeo Investment Manager - EIM SA
 Eurazeo Investment Manager - EIM SA Investment ManagersFinance Eurazeo Investment Manager is an active, long-term manager which invests in the information technology and life sciences sectors, aiming to invest in businesses with quality management teams, high potential in their target market and the capacity to maintain their competitive advantage. EIM invests in European small to medium sized companies providing venture capital at all stages, growth capital and debt financing. The firm also invests in funds throughout primary and secondary transactions. | Finance |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Finance |
AgroParisTech
 AgroParisTech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
CDC Entreprises Innovation
 CDC Entreprises Innovation Financial ConglomeratesFinance Provides investment services | Finance |
STAT-Dx Life SL
 STAT-Dx Life SL Medical SpecialtiesHealth Technology Develops molecular and immunoassay diagnostic systems for clinical decentralized testing | Health Technology |
Sterispine | |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Nova School of Business & Economics
 Nova School of Business & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Dyncaure SAS
Dyncaure SAS Pharmaceuticals: MajorHealth Technology Manufactures non-therapeutic products | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Health Technology |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- Rémi Droller
